Reuters logo
BRIEF-Urogen Pharma announces agreement to license RTGEL for use with Neurotoxins to Allergan
October 14, 2016 / 11:22 AM / in a year

BRIEF-Urogen Pharma announces agreement to license RTGEL for use with Neurotoxins to Allergan

Oct 14 (Reuters) - Allergan Plc :

* Press release - Urogen Pharma announces agreement to license RTGEL for use with Neurotoxins to Allergan

* Urogen Pharma - Allergan to make upfront payment of $17.5 million, as well as potential development and commercial milestones and royalties on net sales Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below